BreathDX.ai is a United States and Malaysian based medical diagnostics company which has developed BREATHGUARD, the first micro gas chromatography based test to noninvasively detect various illnesses using exhaled breath to locate identified volatile organic compounds...
Our mission is to save lives through early noninvasive cancer detection and to become the world's leading breath-based diagnostics company. Our lung cancer test is scheduled to launch commercially Q1 2024 in New York, USA.